| Company Name: |
Cool Pharm, Ltd |
| Tel: |
021-60455363 18019463053 |
| Email: |
sales@coolpharm.com |
|
| | tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Basic information |
| Product Name: | tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate | | Synonyms: | tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate;6-Hydroxymethyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester;2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-6-(hydroxymethyl)-, 1,1-dimethylethyl ester;tert-butyl 6-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;2-Boc-6-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline | | CAS: | 622867-52-1 | | MF: | C15H21NO3 | | MW: | 263.33 | | EINECS: | | | Product Categories: | | | Mol File: | 622867-52-1.mol |  |
| | tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Chemical Properties |
| Boiling point | 403.7±45.0 °C(Predicted) | | density | 1.153±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | pka | 14.44±0.10(Predicted) | | Appearance | White to off-white Solid |
| | tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Usage And Synthesis |
| Uses | N-Boc-6-hydroxymethyl-1,2,3,4-tetrahydroisoquinoline is an intermediate used to prepare phosphonate-substituted HIV protease inhibitors for treatment of AIDS and other viral infections. It is also used in the synthesis of immunosuppressant heterocyclic compdounds for treating or preventing diseases assocd. with EDG receptor mediated signal transduction. | | Synthesis | General procedure for the synthesis of tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate from 2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid: In Example 16, tert-butyl 6-bromomethyl-3,4-dihydro-1H-isoquinoline-2- carboxylate (D-1 ), the intermediate 6-bromomethyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid, was prepared as follows: firstly, under nitrogen protection, the Borane-THF complex (99.17 mL, 99.17 mmol) was slowly added to a solution of 2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid (12.50 g, 45.08 mmol) in anhydrous THF (125.0 mL) via a syringe, and the reaction lasted for 16 h at 25 °C. Subsequently, water (10.0 mL) was slowly added followed by 2.0 M Na2CO3 solution (15.0 mL). The mixture was stirred for 15 min and then diluted with EtOAc to separate the organic layer. The organic layer was washed with 1 M HCl, dried over MgSO4 and concentrated under reduced pressure to give an oil. The oily substance was purified by silica gel chromatography to give the intermediate D-1-1 (11.8 g, 99.3% yield) as a white solid. Next, D-1-1 (9.50 g, 36.1 mmol) and N,N-diisopropylethylamine (9.43 mL, 54.1 mmol) were dissolved in dichloromethane (200.0 mL), triphenylphosphine dibromide (23.79 g, 54.11 mmol) was added, and the reaction was stirred for 1 hr and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography to afford the target product D-1 (8.74 g, 74% yield) as a white solid. | | References | [1] Patent: US2016/24059, 2016, A1. Location in patent: Paragraph 0308-0309 [2] Patent: WO2012/122340, 2012, A1. Location in patent: Page/Page column 77 [3] Patent: US2014/73629, 2014, A1. Location in patent: Paragraph 0100; 0101 [4] Patent: WO2017/160632, 2017, A1. Location in patent: Page/Page column 78; 79 [5] Patent: WO2017/216726, 2017, A1. Location in patent: Page/Page column 643-644 |
| | tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Preparation Products And Raw materials |
|